Vanguard Group’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.07M Hold
9,374,728
﹤0.01% 3212
2025
Q1
$6.15M Hold
9,374,728
﹤0.01% 3093
2024
Q4
$9.56M Sell
9,374,728
-223,049
-2% -$228K ﹤0.01% 2983
2024
Q3
$8.31M Sell
9,597,777
-2,300,640
-19% -$1.99M ﹤0.01% 3048
2024
Q2
$4.26M Sell
11,898,417
-301,951
-2% -$108K ﹤0.01% 3321
2024
Q1
$8.18M Sell
12,200,368
-398,761
-3% -$267K ﹤0.01% 3074
2023
Q4
$6.85M Buy
12,599,129
+68,884
+0.5% +$37.4K ﹤0.01% 3151
2023
Q3
$7.52M Buy
12,530,245
+131,833
+1% +$79.1K ﹤0.01% 3058
2023
Q2
$16.1M Sell
12,398,412
-1,982,497
-14% -$2.58M ﹤0.01% 2682
2023
Q1
$25.3M Buy
14,380,909
+335,300
+2% +$590K ﹤0.01% 2489
2022
Q4
$44.1M Buy
14,045,609
+1,314,500
+10% +$4.13M ﹤0.01% 2245
2022
Q3
$62.4M Buy
12,731,109
+1,205,951
+10% +$5.91M ﹤0.01% 2073
2022
Q2
$47.7M Buy
11,525,158
+1,389,297
+14% +$5.75M ﹤0.01% 2214
2022
Q1
$58.9M Buy
10,135,861
+795,306
+9% +$4.62M ﹤0.01% 2223
2021
Q4
$70.1M Buy
9,340,555
+145,220
+2% +$1.09M ﹤0.01% 2168
2021
Q3
$82.9M Buy
9,195,335
+90,077
+1% +$812K ﹤0.01% 2082
2021
Q2
$109M Sell
9,105,258
-17,059
-0.2% -$204K ﹤0.01% 1958
2021
Q1
$114M Buy
9,122,317
+668,659
+8% +$8.38M ﹤0.01% 1877
2020
Q4
$132M Buy
8,453,658
+327,099
+4% +$5.1M ﹤0.01% 1697
2020
Q3
$76.8M Sell
8,126,559
-345,336
-4% -$3.26M ﹤0.01% 1812
2020
Q2
$75.9M Sell
8,471,895
-82,743
-1% -$741K ﹤0.01% 1799
2020
Q1
$54.5M Buy
8,554,638
+66,134
+0.8% +$421K ﹤0.01% 1837
2019
Q4
$71M Buy
8,488,504
+153,398
+2% +$1.28M ﹤0.01% 1936
2019
Q3
$75.4M Buy
8,335,106
+25,945
+0.3% +$235K ﹤0.01% 1870
2019
Q2
$89.5M Buy
8,309,161
+596,573
+8% +$6.43M ﹤0.01% 1808
2019
Q1
$73.6M Buy
7,712,588
+117,336
+2% +$1.12M ﹤0.01% 1889
2018
Q4
$87.2M Buy
7,595,252
+117,561
+2% +$1.35M ﹤0.01% 1753
2018
Q3
$127M Sell
7,477,691
-686,132
-8% -$11.6M 0.01% 1682
2018
Q2
$116M Buy
8,163,823
+1,220,399
+18% +$17.3M ﹤0.01% 1701
2018
Q1
$132M Buy
6,943,424
+2,463,455
+55% +$46.8M 0.01% 1558
2017
Q4
$73.5M Buy
4,479,969
+548,015
+14% +$8.99M ﹤0.01% 1869
2017
Q3
$59M Buy
3,931,954
+460,273
+13% +$6.9M ﹤0.01% 1959
2017
Q2
$30.6M Buy
3,471,681
+384,031
+12% +$3.38M ﹤0.01% 2265
2017
Q1
$16.1M Buy
3,087,650
+239,544
+8% +$1.25M ﹤0.01% 2536
2016
Q4
$8.69M Buy
2,848,106
+122,362
+4% +$373K ﹤0.01% 2811
2016
Q3
$12.6M Buy
2,725,744
+31,351
+1% +$145K ﹤0.01% 2576
2016
Q2
$15.6M Buy
2,694,393
+234,286
+10% +$1.36M ﹤0.01% 2438
2016
Q1
$14.9M Sell
2,460,107
-62,738
-2% -$380K ﹤0.01% 2415
2015
Q4
$23M Buy
2,522,845
+45,666
+2% +$417K ﹤0.01% 2248
2015
Q3
$14M Buy
2,477,179
+145,445
+6% +$820K ﹤0.01% 2440
2015
Q2
$25.9M Buy
2,331,734
+71,937
+3% +$798K ﹤0.01% 2245
2015
Q1
$35.4M Buy
2,259,797
+114,411
+5% +$1.79M ﹤0.01% 2080
2014
Q4
$32.6M Buy
2,145,386
+101,588
+5% +$1.55M ﹤0.01% 2032
2014
Q3
$22M Buy
2,043,798
+27,317
+1% +$295K ﹤0.01% 2166
2014
Q2
$30.8M Buy
2,016,481
+57,859
+3% +$884K ﹤0.01% 2064
2014
Q1
$35.4M Buy
1,958,622
+184,871
+10% +$3.34M ﹤0.01% 1982
2013
Q4
$24.6M Buy
1,773,751
+101,394
+6% +$1.41M ﹤0.01% 2094
2013
Q3
$17.5M Buy
1,672,357
+260,599
+18% +$2.73M ﹤0.01% 2159
2013
Q2
$11M Buy
+1,411,758
New +$11M ﹤0.01% 2291